Minerva Neurosciences (NERV) earnings date: Nov 4, 2026
Minerva Neurosciences (NERV) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026. Analysts expect EPS of -$0.14.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on NERV
| Last price | $2.35 (+1.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.5% |
| Earnings beat history | Beat the EPS estimate in 0 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Minerva Neurosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Minerva Neurosciences reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Minerva Neurosciences. You can switch it off at any time.
Alert me before NERV reportsFree to start. Creating an account takes under a minute.
Notify me when Minerva Neurosciences reports
Track NERV free Add Minerva Neurosciences to a free ATLAS watchlist and see its next report date in one place.
NERV earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.14 |
| Last report | Aug 7, 2026 · Miss |
| Beat rate (last 4 reports) | 0 of 4 (0%) |
| Average EPS surprise | -2,515.0% |
| Average move around a report | ±3.0% (last 4) |
| Sector | Healthcare · Biotechnology |
Minerva Neurosciences earnings history: last 4 reports
Minerva Neurosciences last reported on Aug 7, 2026: EPS of -$0.17 against an estimate of -$0.01 (-1,600.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 7, 2026 | -$0.01 | -$0.17 | -1,600.0% | Miss | +4.1% |
| Jun 2, 2026 | $0.23 | $0.17 | -26.1% | Miss | -3.3% |
| May 5, 2026 | -$0.13 | -$0.17 | -30.8% | Miss | -1.6% |
| Mar 11, 2026 | -$0.30 | -$25.51 | -8,403.0% | Miss | -3.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for NERV
See the fair value, the probability range and the earnings history of Minerva Neurosciences on its ATLAS page.
Minerva Neurosciences (NERV) stock analysisPlans from €3.99 a month.
Minerva Neurosciences earnings: frequently asked questions
When does Minerva Neurosciences (NERV) report earnings?
Minerva Neurosciences is scheduled to report on Wednesday, November 4, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for NERV?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.14 per share (USD). Estimates can change before the report.
How often does NERV beat earnings estimates?
Of its last 4 reports with a recorded result, Minerva Neurosciences beat the EPS estimate 0 times; the average surprise was -2,515.0%. Past results do not predict the next one.
How much does NERV move around earnings?
Over its last 4 reports the stock moved an average of 3.0% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Minerva Neurosciences beat earnings estimates last quarter?
Minerva Neurosciences last reported on Aug 7, 2026: EPS of -$0.17 against an estimate of -$0.01 (-1,600.0% surprise), a miss.
How much does NERV usually move in a day?
On a normal trading day the ATLAS model puts NERV’s one-day range at about ±4.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer